September 9, 2024

Superluminal Medicines secures $120m in Series A funding round

By PBR Staff Writer

RA Capital Management spearheaded the financing round with contributions from current investors namely Insight Partners, NVentures and Gaingels. New participants in this funding round included Catalio Capital Management,